Investi Stratix
  • Politics
  • Economy
  • Forex
  • Stock
  • Editor’s Pick
  • Politics
  • Economy
  • Forex
  • Stock
  • Editor’s Pick
No Result
View All Result
Investi Stratix
No Result
View All Result

Tesla, Spirit Airlines and CVS Health rise premarket; Nvidia falls

by
November 18, 2024
in Economy
0
Tesla, Spirit Airlines and CVS Health rise premarket; Nvidia falls

Investing.com — US stock futures traded in a mixed fashion Monday, with traders awaiting more corporate earnings as well as speeches from a number of Fed officials.

Here are some of the biggest premarket US stock movers today:

Tesla (NASDAQ:TSLA) stock surged 5.9% following reports from Bloomberg that the incoming Trump administration will establish a federal framework for fully self-driving vehicles and make it a top priority for the Department of Transportation.

Nvidia (NASDAQ:NVDA) stock fell 3.4% amid doubts over the strength of sales of its new Blackwell chips, ahead of the chipmaker’s quarterly earnings on Wednesday.

Spirit Airlines (NYSE:SAVE) stock rose 2.8% after the budget carrier filed for bankruptcy protection after years of mounting losses, stating that it has reached a prearranged deal with its bondholders to help it through the bankruptcy, which it expects to exit in the first quarter of next year.

Ford (NYSE:F) stock rose 0.3% despite the US auto safety regulator stating it had initiated a recall query into about 112,567 of the auto giant’s SUVs over an issue with seat belt retractors.

CVS Health (NYSE:CVS) stock rose 1.9% after the pharmacy chain said it would add four new members to its board in an agreement with Glenview Capital Management, including the hedge fund’s chief executive Larry Robbins.

Super Micro Computer (NASDAQ:SMCI) stock rose over 10% as investors awaited a planned filing that would allow the server maker to avoid being delisted

Astera Labs (NASDAQ:ALAB) stock rose 3% after Citi initiated coverage of the semiconductor stock with a ‘buy’ rating, saying the shares provide artificial intelligence investors with a unique opportunity.

Syndax Pharmaceuticals (NASDAQ:SNDX) stock rose 6% after the FDA approved its Revuforj drug for the treatment of certain leukemia patients.

This post appeared first on investing.com
Previous Post

India’s economic growth needs more affordable interest rates, minister says

Next Post

Fed to cut by 25bps in the next four FOMC meetings says Morgan Stanley

Next Post
Fed to cut by 25bps in the next four FOMC meetings says Morgan Stanley

Fed to cut by 25bps in the next four FOMC meetings says Morgan Stanley

Subscribe to InvestiStratix.com

    Popular News

    Oil prices face litmus test as US-Iran nuclear talks, OPEC meeting to shape market next week

    Oil prices face litmus test as US-Iran nuclear talks, OPEC meeting to shape market next week

    June 30, 2025
    How billionaire Caltagirone could influence Italy’s banking M&A wave

    How billionaire Caltagirone could influence Italy’s banking M&A wave

    June 30, 2025
    Citi Wealth CIO says traders ignoring warning signs in S&P 500

    Citi Wealth CIO says traders ignoring warning signs in S&P 500

    June 29, 2025
    How billionaire Caltagirone could influence Italy’s banking M&A wave

    How billionaire Caltagirone could influence Italy’s banking M&A wave

    June 29, 2025
    Citi Wealth CIO says traders ignoring warning signs in S&P 500

    Citi Wealth CIO says traders ignoring warning signs in S&P 500

    June 28, 2025

    Trending News

    Oil prices face litmus test as US-Iran nuclear talks, OPEC meeting to shape market next week

    Oil prices face litmus test as US-Iran nuclear talks, OPEC meeting to shape market next week

    June 30, 2025
    How billionaire Caltagirone could influence Italy’s banking M&A wave

    How billionaire Caltagirone could influence Italy’s banking M&A wave

    June 30, 2025

    Popular News

    • How billionaire Caltagirone could influence Italy’s banking M&A wave
      June 30, 2025
    • How billionaire Caltagirone could influence Italy’s banking M&A wave
      June 29, 2025

    About Us

    • About us
    • Contact us
    • Privacy Policy
    • Terms & Conditions
    • About us
    • Contact us
    • Privacy Policy
    • Terms & Conditions

    Copyright © 2025 investistratix.com | All Rights Reserved

    No Result
    View All Result
    • Politics
    • Economy
    • Forex
    • Stock
    • Editor’s Pick

    Copyright © 2025 investistratix.com | All Rights Reserved